Article Details
Retrieved on: 2022-06-03 19:24:01
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Pfizer's Xalkori and Roche drug Rozlytrek have FDA approvals for treating ROS1-positive NSCLC that has spread. Meanwhile, Rozlytrek and Bayer drug ...
Article found on: medcitynews.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here